http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2432359-C2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e78cb265574dc412f4582a14a746d7df |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 |
filingDate | 2006-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2011-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53dfddf8ac013dd1f0419030e0390394 |
publicationDate | 2011-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2432359-C2 |
titleOfInvention | APPLICATION OF FUSED POLYPEPTIDE CONTAINING MeCP2 PROTEIN AND PROTEIN TRANSDUCTION DOMAIN, PHARMACEUTICAL COMPOSITION CONTAINING SUCH PROTEIN AND METHOD OF TREATING AND/OR PREVENTING DEVELOPMENTARY NEUROPATHY |
abstract | FIELD: medicine. n SUBSTANCE: invention refers to applications of a fused polypeptide containing (i) MeCP2 protein and (ii) a protein transduction domain for preparing a drug for treating and/or preventing a developmentary neuropathy, and also to the pharmaceutical compositions containing such polypeptide, and a method of treating the developmentary neuropathy. n EFFECT: invention allows compensating MeCP2 function loss in damaged nerve cells. n 11 cl, 8 dwg, 2 tbl, 11 ex |
priorityDate | 2006-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 285.